Back to the search results

Kerckhoff-Klinik GmbH

Benekestr. 2 - 8
61231 Bad Nauheim

Phone: 06032-996-0
Fax: 06032-996-2618
Mail: ed.kinilk-ffohkcrek@ofni

http://www.kerckhoff-klinik.de

Basic information

Number of beds: 381
Number of specialist departments: 7

Number of inpatient cases: 11.588
Number of outpatient cases: 41.021

Hospital owners: Alleingesellschafter: Stiftung William G. Kerckhoff Herz- und Rheumazentrum Bad Nauheim, Rechtsträger: Kerckhoff-Klinik GmbH Bad Nauheim
Type of provider: freigemeinnützig

Specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	yes
Bezeichnung
Teilnahme externe Qualitätssicherung	does not apply
Bezeichnung
Teilnahme externe Qualitätssicherung	yes

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of the minimum quantity agreement
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ25	Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ03	Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules
CQ19	Quality assurance measures for proton therapy in patients with inoperable non-small cell lung cancer (NSCLC) of UICC stages I-III
CQ18	Measures for quality assurance of positron emission tomography in patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma for interim staging after chemotherapy to decide on the continuation of therapy
CQ01	Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
137	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
100	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
93	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Drug therapy safety

Steering committee

Drug commission

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
Bereitstellung von Sicherheitswerkbänken zur sterilen Vorbereitung von Infusionslösungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
Elektronische Anforderung von Arzneimitteln

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Special instrument-based equipment

Research & teaching

Job

FL06 - Participation in multi-centre phase III/IV studies

Explanation

zurzeit stattfindende Studien: Phase III: 13 Studien; Phase IIIb: 2 Studien; Phase 4: 7 Studien

FL04 - Project-related cooperation with colleges and universities

Explanation

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

FL05 - Participation in multi-centre Phase I/II studies

Explanation

zurzeit stattfindende Studien: Phase II: 2 Studien; Phase IIb: 2 Studien; Phase IIb/III: 1 Studien

FL09 - Doctoral supervision

Explanation

Von den Mitarbeitern der Forschungsgesellschaft mbH, primär durch den Medizinischen Direktor, werden verschiedene Doktorarbeiten betreut. Dabei wurden verschiedene vorwiegend klinisch orientierte Themen von externen Medizinstudenten sowie Assistenzärzten behandelt.

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

15 Ärzte der Kerckhoff-Klinik sind am Universitätsstandort Gießen Dozent bzw. Lehrbeauftragter. Die Dozenturen sind aufgeführt im Vorlesungsverzeichnis der Universitäten Gießen, Marburg und Frankfurt

Training